1CM Inc (MILFF) AI Stock Analysis

14 Followers

1CM Inc

(Other OTC:MILFF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Rapid Revenue GrowthRevenue scaling of roughly 54% demonstrates strong recent expansion from the company’s earlier base and provides a foundation for operating leverage. If this growth persists, it can broaden market reach, support reinvestment, and improve the durability of the business model over the next several quarters.

Negative Factors

Extremely Thin Gross MarginA gross margin near 1% leaves very little protection against cost increases, pricing pressure, or unfavorable mix changes. Even with revenue growth and positive net income, such limited gross profitability makes earnings more vulnerable and may constrain the company’s ability to reinvest sustainably.

1CM Inc (MILFF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $26.30M
Dividend Yield: ―
Average Volume (3M): 5,972
Price to Earnings (P/E): 4.5
Beta (1Y): -0.95
Revenue Growth: 8.65%
EPS Growth: 173.83%
Country: US
Employees: 11
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

1CM Inc Business Overview & Revenue Model

Company Description

1CM Inc. functions as a diverse enterprise within the cannabis industry. The company's primary focus is on utilizing technology to cater to individual consumers, with the objective of making cannabis markets more accessible and inclusive. Previously...

1CM Inc Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

MILFF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSE:LABS	57Neutral	CAD 27.77M	-10.00	-13.79%	―	-9.31%	66.84%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:ROMJ	44Neutral	CAD 28.72M	-17.28	-4.00%	―	16.66%	-1007.41%
TSE:AVCN	42Neutral	CAD 13.44M	-4.54	-65.40%	―	-3.32%	-34.15%
TSE:GWAY	41Neutral	CAD 10.69M	-3.62	-35.33%	―	-1.41%	-78.91%
TSE:PCLO	23Underperform	CAD 8.41M	-2.41	28.59%	―	0.90%	57.73%

* Healthcare Sector Average

Performance Comparison

MILFF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
MILFF	1Cm Inc.	0.22	0.07	42.95%
TSE:LABS	Medipharm Labs (Otc)	0.07	-0.01	-7.14%
TSE:PCLO	Pharmacielo	0.04	0.00	0.00%
TSE:ROMJ	Rubicon Organics	0.42	-0.07	-14.14%
TSE:AVCN	Avicanna Inc	0.10	-0.13	-55.56%
TSE:GWAY	Greenway Greenhouse Cannabis Corp.	0.08	-0.10	-55.56%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

1CM Inc AI Stock Analysis